Safety risk sinks Cargo Therapeutics’ cancer cell therapy prospect

The latest stories trending on MedCity News.

Editor's Pick

Top Story Safety Risk Sinks Cargo Therapeutics' Cancer Cell Therapy Prospect, Leading to 50% Staff Cut Phase 2 data for Cargo Therapeutics' CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. Sponsored A Data-Driven Guide to Patient Access Success. Presented by Relatient Managing large volumes of data, often across various systems, is a significant challenge for growing healthcare organizations.  This ebook will help you navigate what truly matters and find improvements in patient access and operational efficiency. Download it today!

Featured News

Telehealth Clinic Hone Health Secures $33M, Acquires Home Health Company Hone Health's Series A round included participation from Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs and Agent Capital. In total, the company has raised $39 million. Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer's Disease As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis. The Most Overlooked Feature with AI Scribes: Coding Awareness By insisting on coding-aware AI solutions, health systems can ensure that these technologies fulfill their transformative promise, reducing clinician burnout and administrative burden, improving patient care and communication, and accurately capturing what occurred during an encounter.

Resources

AI in Healthcare: The Next Chapter Presented by MedCity News The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe